Westlake Chemical Partners LP filed its quarterly report on Form 10-Q with the SEC on August 5, 2026, covering the three- and six-month periods ended June 30, 2026, and reporting net income of $82.4 million for the second quarter.

Key Highlights

  • Q2 2026 total net sales: $297.1 million, essentially flat compared with $297.1 million in Q2 2025, according to the filing.
  • Q2 2026 net income: $82.4 million, down from $85.8 million in Q2 2025, as reported in the consolidated statements of operations.
  • Six-month net income: $164.0 million for the first half of 2026, compared with $128.1 million for the same period in 2025.
  • Net income per common unit (basic and diluted): $0.40 for Q2 2026 and $0.81 for the six months ended June 30, 2026.
  • Total assets: $1.217 billion as of June 30, 2026, compared with $1.257 billion at December 31, 2025.
  • Units outstanding: 35,245,879 common units as of July 29, 2026, per the cover page.
  • Cash and cash equivalents: $49.3 million at June 30, 2026, up from $44.3 million at December 31, 2025.

Westlake Chemical Partners LP Second-Quarter 2026 Financial Performance

According to the filing, Westlake Chemical Partners LP (NYSE: WLKP) reported total net sales of $297.1 million for the three months ended June 30, 2026, compared with $297.1 million in the same period of 2025. Net sales to Westlake Corporation were $238.0 million in Q2 2026, down from $269.1 million a year earlier, while net co-products, ethylene, and other sales to third parties rose to $59.1 million from $28.0 million in Q2 2025. Cost of sales was $202.3 million, leaving a gross profit of $94.8 million for the quarter.

The filing disclosed income from operations of $87.3 million for Q2 2026, compared with $91.2 million for Q2 2025. Interest expense payable to Westlake was $5.1 million in Q2 2026, down from $5.9 million a year earlier. Of the $82.4 million in Q2 net income, $68.1 million was attributed to the noncontrolling interest in OpCo, with $14.2 million attributable to Westlake Chemical Partners LP and its limited partners. Distributions to unitholders totaled $16.6 million in each of the first and second quarters of 2026.

For the six months ended June 30, 2026, the partnership reported net cash provided by operating activities of $240.0 million, compared with $54.9 million for the same period in 2025. The filing noted additions to property, plant and equipment of $18.0 million for the first half of 2026. Long-term debt payable to Westlake remained at $399.7 million at both June 30, 2026, and December 31, 2025. Total equity was $769.4 million at June 30, 2026, down from $802.4 million at December 31, 2025, reflecting distributions to the noncontrolling interest in OpCo of $163.7 million over the first six months of 2026.

What Was Disclosed

The 10-Q for the period ended June 30, 2026, disclosed quarterly and year-to-date income statements, balance sheet data, cash flow information, and equity changes for Westlake Chemical Partners LP, a Delaware limited partnership with common units listed on the New York Stock Exchange.